Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...
Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
How did Tesla, and Space X CEO lost 40 pounds? In an exclusive interview he revealed his weight loss diet and one medicine ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.